Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
American Journal of Surgery
|
February 1, 1995
Development and characterization of normal colonic epithelial cell lines derived from normal mucosa of patients with colon cancer
J S Stauffer, L A Manzano, G C Balch, et al.
Scientific Reports
|
October 26, 2021
Oxytocin increases physiological linkage during group therapy for methamphetamine use disorder: a randomized clinical trial
Katherine R Thorson, Scott M McKernan, Tessa V West, et al.
Psychopharmacology
|
May 4, 2016
The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study
Josh D Woolley, Peter A Arcuni, Christopher S Stauffer, et al.
Psychoneuroendocrinology
|
August 4, 2020
Automatic Imitation in Comorbid PTSD & Alcohol Use Disorder and Controls: an RCT of Intranasal Oxytocin
Tyler E Morrison, Lize De Coster, Christopher S Stauffer, et al.
Frontiers in Psychiatry
|
December 21, 2023
Group psychedelic therapy: empirical estimates of cost-savings and improved access
Elliot Marseille, Christopher S Stauffer, Manish Agrawal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2000
The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton
P A Randazzo, J Andrade, K Miura, et al.
Frontiers in Psychiatry
|
March 31, 2023
Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder
Jonathan Brett, Elizabeth Knock, P Todd Korthuis, et al.
The Journal of Biological Chemistry
|
March 29, 2000
Phosphoinositide-dependent activation of the ADP-ribosylation factor GTPase-activating protein ASAP1. Evidence for the pleckstrin homology domain functioning as an allosteric site
J L Kam, K Miura, T R Jackson, et al.
Journal of Substance Abuse Treatment
|
August 4, 2020
Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial
Christopher S Stauffer, Jenna M Moschetto, Scott McKernan, et al.
The American Journal of Psychiatry
|
January 1, 2024
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary
Michael D Alpert, Kelley C O'Donnell, Casey A Paleos, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
American Journal of Surgery
|
February 1, 1995
Development and characterization of normal colonic epithelial cell lines derived from normal mucosa of patients with colon cancer
J S Stauffer, L A Manzano, G C Balch, et al.
Scientific Reports
|
October 26, 2021
Oxytocin increases physiological linkage during group therapy for methamphetamine use disorder: a randomized clinical trial
Katherine R Thorson, Scott M McKernan, Tessa V West, et al.
Psychopharmacology
|
May 4, 2016
The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study
Josh D Woolley, Peter A Arcuni, Christopher S Stauffer, et al.
Psychoneuroendocrinology
|
August 4, 2020
Automatic Imitation in Comorbid PTSD & Alcohol Use Disorder and Controls: an RCT of Intranasal Oxytocin
Tyler E Morrison, Lize De Coster, Christopher S Stauffer, et al.
Frontiers in Psychiatry
|
December 21, 2023
Group psychedelic therapy: empirical estimates of cost-savings and improved access
Elliot Marseille, Christopher S Stauffer, Manish Agrawal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2000
The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton
P A Randazzo, J Andrade, K Miura, et al.
Frontiers in Psychiatry
|
March 31, 2023
Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder
Jonathan Brett, Elizabeth Knock, P Todd Korthuis, et al.
The Journal of Biological Chemistry
|
March 29, 2000
Phosphoinositide-dependent activation of the ADP-ribosylation factor GTPase-activating protein ASAP1. Evidence for the pleckstrin homology domain functioning as an allosteric site
J L Kam, K Miura, T R Jackson, et al.
Journal of Substance Abuse Treatment
|
August 4, 2020
Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial
Christopher S Stauffer, Jenna M Moschetto, Scott McKernan, et al.
The American Journal of Psychiatry
|
January 1, 2024
Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary
Michael D Alpert, Kelley C O'Donnell, Casey A Paleos, et al.
Page
of 11